7 funding opportunities are listed in this category

Targeted RFP – Biomedical Research: Establishment of a Research Consortium to Explore the Barriers to and Potential for Eradication of HIV Infection
amfAR, The Foundation for AIDS Research
All Regions
03/25/2010
$300,000

Targeted RFP – Biomedical Research: Establishment of a Research Consortium to Explore the Barriers to and Potential for Eradication of HIV Infection

Application Deadline: March 25, 2010

Available Support
amfAR, The Foundation for AIDS Research, is pleased to announce plans to establish and support a consortium—consisting of several collaborations—of biomedical researchers to explore the barriers to and potential for eradicating HIV infection.

Funding will be available for:

Collaborations—Each collaboration is funded for a total of up to $300,000 for direct costs plus up to 20 percent for indirect costs. The performance period for collaborations funded under this RFP will be for one year starting May 1, 2010, and may be renewable for subsequent years. Each collaboration must consist of at least two interrelated research projects and involve at least two independent, faculty-level researchers.

Background and Areas of Interest
amfAR's research program is driven by the Foundation's mission to end the global AIDS epidemic through innovative research. amfAR plays a uniquely important role in AIDS research, identifying critical gaps in our knowledge of HIV and AIDS and supporting groundbreaking studies that often lack the preliminary data required by more traditional funders. The Foundation's research program focuses on efforts to prevent HIV infection among vulnerable populations and to improve treatment, with the ultimate goal of eradicating the virus in people living with HIV infection.

This RFP solicits proposals for collaborations to explore the obstacles to and strategies for eradicating HIV infection. Highly active antiretroviral therapy (HAART) has significantly improved the health of individuals infected with HIV-1. However, if therapy is interrupted, there is a rapid resumption of viral replication. Understanding the mechanisms by which the virus is able to persist in the face of therapy is necessary in order to identify strategies that may interrupt viral persistence and ultimately lead to viral eradication. amfAR wishes to establish a consortium consisting of several collaborations. The purpose of the consortium is to explore barriers to and the potential for the eradication of HIV infection as a condition requiring medical treatment, i.e., a sterilizing or functional cure.

amfAR would like to fund one collaboration in each of the following three areas. Some, but not all, potential topics of interest within each of the three collaboration areas are listed:

Sterilizing cure: i.e., eliminating HIV from the body of an infected person
Gene therapy techniques/vectors
"Shock and kill” strategies
Methods to identify and specifically target infected cells
Replication and/or exploration of factors contributing to the Berlin patient outcome
Functional cure: i.e., achieving a state of persistent HIV infection without the need for medical treatment
What can be learned from specific populations of interest such as elite controllers, long-term non-progressors, and patients who initiate therapy during acute infection? How can this information be applied to devising a functional cure?
What are the immune or other implications of persistent infection, even in the absence of disease?
Characterizing viral reservoirs:
Which cells under which conditions contribute which roles to the reservoir(s)?
Mechanisms for reservoir maintenance
Assays to measure perturbation of reservoir
Latency and the extent to which it exists in different cell types
Nature and origin of blips
Animal models

Definitions and exclusions
Each collaboration must consist of at least two interrelated research projects and involve at least two independent, faculty-level researchers. All principal and collaborating investigators must be doctoral level. Each collaboration must have access to and describe how they would use patients or clinical samples as part of their research plan.

Any collaboration participant, i.e., principal or collaborating investigator, key personnel (including postdoctoral researchers and their mentors), and consultants, may be part of only one application.

Special notes
Please note that this RFP is differs from recent ones in the following ways:

Grants will be awarded to support collaborations, not individual researchers.
The direct cost maximum is $300,000.
Funding may be renewable.
Pre-submission forms and letters of intent are not required.

Eligibility and Qualifications
Collaborative research grants are awarded to nonprofit institutions worldwide to support investigator-led projects approved by the Foundation. They are not awarded to for-profit entities or to individuals. With the exception of colleges or universities, governmental units or agencies are not eligible to receive funding through grants made under this RFP. The recipient organization will be legally and financially responsible for the use of grant funds.

Principal and collaborating investigators must be doctoral-level researchers and hold a faculty-level (or equivalent) position.

The principal investigator must be affiliated with the applicant organization. The principal investigator will be expected to actively lead one of the component projects; actively participate in the development, implementation, and analysis of the project as whole; and be responsible for coordinating the preparation and submission of required progress reports.

Collaborating investigators may be affiliated with any research organization that is not a governmental unit or agency. Collaborating investigators are expected to actively lead a component project and play an active role in the development, implementation, and analysis of the project as a whole.

Forms, Instructions, and Deadlines
The preferred method for obtaining application forms is to e-mail amfAR at grants@amfAR.org. We will send a complete set of forms and instructions.

Completed applications are to be e-mailed to grantapps@amfar.org no later than March 25, 5:00 p.m. EDT.

Please make sure the body of the e-mail includes the principal investigator’s name and contact information.

Important Notice
Pre-submission notice and letters of intent are NOT required under this RFP. Applications that are received late, are incomplete, or exceed word limitations will not be accepted for review. Fax submissions are not accepted.

The Research Plan consists of separate research plans of no more than 2,500 words for each of the component projects covering background and rationale, preliminary studies, specific aims, experimental design, procedures, and data analysis to be used. There are no forms for the research plan; formatting and submission requirements are detailed in the application instructions.

Send one hard copy of the Collaboration Information Form (bearing original signatures) to:

amfAR Grants
120 Wall Street, 13th Floor
New York, NY 10005-3908, USA

If you are not able to download the forms or have questions about the application requirements, please e-mail grants@amfar.org or telephone 212-806-1752.

Submission of an application is not a guarantee of funding. The review and approval process is highly competitive.

Cell Biologist, Molecular Biologist , Physician Researcher, Scientist
Pasteur Foundation Postdoctoral Fellowship Program in Paris
Pasteur Foundation
All Regions
02/12/2010
$70,000

Pasteur Foundation Postdoctoral Fellowship Program in Paris

In collaboration with the Institut Pasteur, the Pasteur Foundation administers this program to bring U.S.
postdoctoral researchers to work in Pasteur laboratories in Paris thanks to the generosity of our U.S. donors.
Guided by the institute's administration which seeks to develop international exchanges to ensure the vitality
of Institut Pasteur labs, this program is for American citizens and does not apply to candidates already in
France . Fellowships are $70,000 ($55,000 fellowship plus $15,000 bench fees to support the research) per
year for a term of three years and are not renewable. Financing for the second and third years is contingent
upon positive annual review by the host lab head. Candidates are expected to commit to a three-year stay .

The first step is to identify an appropriate and willing host lab at the Institut Pasteur. See the “programs” page of our website (www.pasteurfoundation.org) for a list of labs at the institute. If you find a lab to sponsor you, you are all set to apply!

Fellowship Program Deadline

Dossiers must be received by February 12, 2010
Fellowship candidates who respond to the February 2010 call for applicants will be notified in April 2010; recipients must begin the fellowship by December 1, 2010.

Pasteur Foundation
420 Lexington Avenue, Suite 1654
New York, New York 10170

Phone: 212.599.2050
Email: PasteurUS@aol.com

Biochemist, Biostatiscian, Cell Biologist, Chemist, Junior Investigator, Junior Researcher, Junior Scientist, Neurobiologist, New Investigator, New Researcher, Physician Researcher, Virologist, Young Investigator, Young Scientist
Michael J. Fox Foundation for Parkinson’s Research Request for Applications for Edmond J. Safra Core Programs for PD Research
Michael J. Fox Foundation for Parkinson’s Research
All Regions
06/01/2010
$0
Michael J. Fox Foundation for Parkinson’s Research Request for Applications for Edmond J. Safra Core Programs for PD Research

Program Goal
With the current Request for Applications (RFA), The Michael J. Fox Foundation for Parkinson’s Research
(MJFF) seeks investigators to join the effort to develop new treatments and ultimately a cure for Parkinson’s
disease (PD). The Edmond J. Safra Core Programs for PD Research, part of our annual Pipeline Programs, is a
series of three funding opportunities that seek investigator-initiated proposals focused on the following critical
points along the translational pathway to new PD therapies:

· Testing Novel Hypotheses: Funding from our Rapid Response Innovation Awards program quickly
supports high-risk, high-reward projects with little to no existing preliminary data, but potential to
significantly impact our understanding or treatment of PD.
· Validating Novel Targets: Funding from our Target Validation program supports work demonstrating
whether modulation of a novel biological target has impact in a PD-relevant animal model – an essential
early step to the development of potential targeted therapies.
· Clinical Testing of Novel Therapies: Funding from our Clinical Intervention Awards program supports
clinical testing of promising PD therapies that may significantly and fundamentally improve treatment for
people with PD.

The Pipeline Programs, including The Edmond J. Safra Core Programs for PD Research, reflect our portfolio
approach to supporting work across multiple stages of development. Applicants are encouraged to carefully
consider the specific goals of each funding program to match the state of development for their project. Each
program requires submission of a custom ‘pre-proposal’ form summarizing the novel hypothesis, new target or
clinical trial being proposed. Applicants should not submit the same idea into multiple programs; rather, choose
the stage that is right for you. MJFF staff may choose at its discretion to move a proposal into the program that it
feels is most appropriate to the apparent stage of work.

Companies interested in support for early hypothesis testing, target validation or clinical efforts are welcome to
apply to the above programs. However, companies seeking support for preclinical therapeutic development
should also consider the separately launched, industry-only Therapeutics Development Initiative. Please see the
MJFF website for more information (www.michaeljfox.org).

Pre-proposals Due

Spring: December 15, 2009 6:00pm US ET
Fall: June 1, 2010 6:00pm US ET

For additional information about this initiative, contact the Foundation at research@michaeljfox.org.

If you would like to contact the Foundation, please send an email, call toll-free at 1-800-708-7644, or contact us by regular mail at the following address:

The Michael J. Fox Foundation for Parkinson's Research
Church Street Station
P.O. Box 780
New York, NY 10008-0780
Cell Biologist, Molecular Biologist , Neurochemist, Neurologist, Neuroscientist, Neurosurgeon, Pharmaceutical Scientist , Pharmacologist, Physician Researcher
American College of Phlebology Junior Faculty Investigator Grant
American College of Phlebology
All Regions
04/01/2010
$70,000

American College of Phlebology Junior Faculty Investigator Grant

The ACP Junior Faculty Investigator Grant Program will assist new investigators with a career interest in phlebology research in initiating a basic, pre-clinical, or pilot clinical research project of importance to the field of Phlebology. This Program is expected to: 1) generate pilot data that enhances the recipient's ability to independently obtain major grant funding for future Phlebology research; and 2) enhance the recipient's ability to independently design, conduct, and report Phlebology research. The Program's long-term goal is to promote the development of a future generation of phlebology research leaders.

Eligibility
Junior faculty investigators with an MD, DO, PhD, or equivalent degree from an accredited educational institution are eligible. Non-ACP members will be considered, but ACP members will be given preference. Applicants must not have been recipients of major grant support (exceeding $50,000). Established investigators at the Associate Professor or Full Professor level are not eligible. To ensure balance, independence, objectivity, and ethical rigor in its funded research activities, all research applicants are required to complete a Financial Disclosure Statement. A full disclosure of any professional business dealings and/or interests in for-profit commercial entities (medical device or pharmaceutical companies, as well as private practices), is required by all applicants. This disclosure will not preclude eligibility of an applicant, rather it will be weighed in the grant approval process.

Award
This grant provides $70,000 for one year. Funds may be used for Investigator salary support, salaries of research assistants working on the project, supplies, service function charges, travel expenses for 1-2 related conferences, and completion of a research education program. Consulting expenses, institutional indirect costs, and office expenses will not be funded. Investigators must spend at least 40% of their time on the project.

We will begin accepting applications in the fall of 2009. Applications are DUE on April 1, 2010.

American College of Phlebology
101 Callan Avenue, Suite 210
San Leandro, California
94577 USA
Phone 510.346.6800
Fax 510.346.6808

Junior Faculty, Junior Investigator, Junior Researcher, Junior Scientist, Physician Researcher, Vascular Surgeon
American College of Phlebology Research Trainee Grant
American College of Phlebology
All Regions
04/01/2010
$45,000

American College of Phlebology Research Trainee Grant

The ACP Research Trainee Grant Program is designed to provide young investigators not yet professionally established in the phlebological sciences with an opportunity to gain insight into scientific investigation in the field of phlebology. The Program's long-term goal is to promote the development of a future generation of phlebology research leaders.

Eligibility
Trainees in graduate-level medical or research programs (e.g. medical students, residents, fellows or post-doctoral students) are eligible. Trainees must be supervised by a designated research mentor at their institution who has an MD, DO, PhD, or equivalent degree. Applicants must not have previously received major grant funding (exceeding $50,000). To ensure balance, independence, objectivity, and ethical rigor in its funded research activities, all research applicants are required to complete a Financial Disclosure Statement. A full disclosure of any professional business dealings and/or interests in for-profit commercial entities (medical device or pharmaceutical companies, as well as private practices), is required by all applicants. This disclosure will not preclude eligibility of an applicant, rather it will be weighed in the grant approval process.

Award
This grant provides $45,000 for one year. Funds may be used for Investigator salary support, salary for research assistants, supplies, service function charges, and travel expenses for attendance at 1-2 related conferences. Funds may also be used to fulfill the research education requirement associated with this program. Consulting expenses, institutional indirect costs, office expenses, and salary for research mentors will not be funded. Investigators must spend at least 50% of their time on the proposed project.

We will begin accepting applications in the fall of 2009. Applications are DUE on April 1, 2010.

American College of Phlebology
101 Callan Avenue, Suite 210
San Leandro, California
94577 USA
Phone 510.346.6800
Fax 510.346.6808

Junior Investigator, Junior Researcher, Junior Scientist, Medical Resident, Medical Student, New Investigator, New Researcher, Novice Researcher, Young Investigator, Young Scientist
American College of Phlebology Research In-Practice Grant
American College of Phlebology
All Regions
04/01/2010
$24,000

American College of Phlebology Research In-Practice Grant

The ACP Research-In-Practice Grant is designed to assist clinical phlebologists who are not established as independent researchers in initiating a clinical research project of importance to the field of phlebology. The long-term intent of this program is to foster the research education and development of clinical phlebologists who are capable of active participation in and/or leadership of clinical trials of phlebological therapies.

Eligibility
Investigators with an MD, DO, PhD, or equivalent degree are eligible. Non-ACP members will be considered, but ACP members will be given preference. Applicants must not have been recognized as independent investigators or recipients of major grant support (exceeding $50,000). To ensure balance, independence, objectivity, and ethical rigor in its funded research activities, all research applicants are required to complete a Financial Disclosure Statement. A full disclosure of any professional business dealings and/or interests in for-profit commercial entities (medical device or pharmaceutical companies, as well as private practices) is required by all applicants. This disclosure will not preclude eligibility of an applicant, rather it will be weighed in the grant approval process.

Award
This grant provides $24,000 for one year. Funds may be used for salaries for research assistants working on the project, supplies, service function charges, travel expenses for attendance at 1-2 related conferences, and completion of a research education program. Consulting expenses, institutional indirect costs, and office expenses will not be funded.

We will begin accepting applications in the fall of 2009. Applications are DUE on April 1, 2010.

American College of Phlebology
101 Callan Avenue, Suite 210
San Leandro, California
94577 USA
Phone 510.346.6800
Fax 510.346.6808

New Investigator, New Researcher, Physician Researcher
Michael E. DeBakey Journalism Awards
Foundation for Biomedical Research
All Regions
04/30/2010
$0

Michael E. DeBakey Journalism Awards

The Michael E. DeBakey Journalism Awards, named after FBR’s late chairman Dr. Michael E. DeBakey, honor professional journalists whose reporting has enhanced public understanding of how the humane and responsible use of animal models leads to medical and scientific discoveries. FBR also welcomes entries that demonstrate how animal rights extremism poses a serious threat to researchers and the future of science.

Awards are presented for outstanding investigative or interpretive reporting published, broadcast or posted online between April 1, 2009 and March 31, 2010. Award winners will receive a Michael E. DeBakey Award and a trip to Washington, D.C., to attend the awards ceremony at the Mayflower Hotel.

Entries may be submitted in the following categories:

* Print (large market)
* Print (small market)
* Print series
* Television
* Radio
* Internet

Entries must be accompanied by the following: a cover letter from journalist or employer, a biography of journalist, letter of consent from journalist and letter(s) of support (optional).

Submit by April 30, 2010 to:

info@fbresearch.org, Subject: The Micheal E. DeBakey Journalism Awards

or

Foundation for Biomedical Research
818 Connecticut Avenue NW, Suite 900
Washington DC 20006
Attention: The Michael E. DeBakey Journalism Awards

Journalist